CN118506984B - Personalized management system for breast milk fortifier of premature infant - Google Patents
Personalized management system for breast milk fortifier of premature infant Download PDFInfo
- Publication number
- CN118506984B CN118506984B CN202410955240.0A CN202410955240A CN118506984B CN 118506984 B CN118506984 B CN 118506984B CN 202410955240 A CN202410955240 A CN 202410955240A CN 118506984 B CN118506984 B CN 118506984B
- Authority
- CN
- China
- Prior art keywords
- breast milk
- fortifier
- protein
- milk fortifier
- energy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Dairy Products (AREA)
Abstract
Description
技术领域Technical Field
本申请涉及数据管理的技术领域,尤其是涉及一种早产儿母乳强化剂个体化管理系统。The present application relates to the technical field of data management, and in particular to an individualized management system for premature infant breast milk fortifiers.
背景技术Background Art
早产、窒息和感染性疾病是新生儿死亡的三大主要原因。早产儿免疫力低下,各系统发育不健全,住院期间容易发生各种并发症,而营养支持在早产儿的成功救治中起着重要作用。美国儿科学会推荐母乳喂养的早产儿使用母乳强化剂(HMF),以确保满足早产儿预期的营养需求。母乳强化剂是包含蛋白质、碳水化合物、矿物质(钙、磷、铁、锌、锰、镁、铜)、微量元素以及维生素和电解质等多种营养素的一种营养强化剂。因母乳中的某些营养素含量不能满足早产儿的生长需求,需要在母乳喂养的同时添加母乳强化剂,既能使早产儿获得母乳喂养的益处,又能满足其快速生长发育的营养需求。母乳强化剂的应用在国内运用的时间尚短,并且目前的临床研究大多是关于早产儿应用母乳强化剂的必要性及安全性方面,个体化强化方案及应用母乳强化剂的研究相对较少。如何根据母乳中蛋白质含量、早产儿生理成熟度和生长情况安全地调整母乳强化剂的添加剂量是新生儿营养领域的重要问题。Premature birth, asphyxia and infectious diseases are the three main causes of neonatal death. Premature infants have low immunity and incomplete development of various systems. They are prone to various complications during hospitalization, and nutritional support plays an important role in the successful treatment of premature infants. The American Academy of Pediatrics recommends the use of human milk fortifier (HMF) for premature infants who are breastfed to ensure that the expected nutritional needs of premature infants are met. Breast milk fortifier is a nutritional fortifier that contains multiple nutrients such as protein, carbohydrates, minerals (calcium, phosphorus, iron, zinc, manganese, magnesium, copper), trace elements, vitamins and electrolytes. Because the content of some nutrients in breast milk cannot meet the growth needs of premature infants, it is necessary to add breast milk fortifiers while breastfeeding, so that premature infants can obtain the benefits of breastfeeding and meet their nutritional needs for rapid growth and development. The application of breast milk fortifiers in China has been relatively short, and most of the current clinical studies are about the necessity and safety of using breast milk fortifiers for premature infants. There are relatively few studies on individualized fortification programs and the use of breast milk fortifiers. How to safely adjust the dosage of human milk fortifier according to the protein content in breast milk and the physiological maturity and growth of premature infants is an important issue in the field of neonatal nutrition.
发明内容Summary of the invention
为解决上述问题,本发明的技术方案为:To solve the above problems, the technical solution of the present invention is:
一种早产儿母乳强化剂个体化管理系统,它包括信息获取模块、母乳含量分析模块、血尿素氮测量模块、策略生成模块;其中:A premature infant breast milk fortifier individualized management system, comprising an information acquisition module, a breast milk content analysis module, a blood urea nitrogen measurement module, and a strategy generation module; wherein:
信息获取模块:获得目标早产儿的出生天数、体重和当天母乳喂养量;获取不同母乳强化剂品牌蛋白质和能量(优选的,不同母乳强化剂品牌的蛋白质和能量通过查阅说明书获得,或通过母乳分析仪测量);Information acquisition module: obtaining the birth day, weight and breast milk feeding amount of the target premature infant on the same day; obtaining the protein and energy of different brands of breast milk fortifiers (preferably, the protein and energy of different brands of breast milk fortifiers are obtained by consulting the instructions or measured by a breast milk analyzer);
母乳含量分析模块:测量目标产妇母乳中的蛋白质和母乳能量;Breast milk content analysis module: measures the protein and breast milk energy in the target mother’s breast milk;
血尿素氮测量模块:所述目标早产儿使用母乳强化剂后,血尿素氮测量模块监测目标早产儿的血尿素氮水平;Blood urea nitrogen measurement module: after the target premature infant uses the breast milk fortifier, the blood urea nitrogen measurement module monitors the blood urea nitrogen level of the target premature infant;
策略生成模块:基于目标早产儿的出生天数和体重、母乳量、母乳蛋白质、母乳能量、不同母乳强化剂品牌蛋白质和能量、早产儿摄入的蛋白/能量比,生成基于母乳分析计算的母乳强化剂袋数D1;基于每袋母乳强化剂克数、母乳强化剂使用天数和血尿素氮水平,生成调整母乳强化剂的策略。Strategy generation module: Based on the birth days and weight of the target premature infants, the amount of breast milk, breast milk protein, breast milk energy, protein and energy of different brands of breast milk fortifiers, and the protein/energy ratio consumed by premature infants, the number of bags of breast milk fortifier D1 calculated based on breast milk analysis is generated; based on the grams of breast milk fortifier per bag, the number of days the breast milk fortifier is used, and the blood urea nitrogen level, a strategy for adjusting breast milk fortifiers is generated.
进一步的,所述基于目标早产儿的出生天数和体重、母乳量、母乳蛋白质、母乳能量、不同母乳强化剂品牌蛋白质和能量、早产儿摄入的蛋白/能量比生成母乳强化剂的添加袋数包括:Furthermore, the number of bags of breast milk fortifier to be added based on the birth days and weight of the target premature infant, the amount of breast milk, breast milk protein, breast milk energy, protein and energy of different breast milk fortifier brands, and the protein/energy ratio of the premature infant includes:
对不同母乳强化剂品牌进行编号,可自由选择或输入;Different brands of human milk fortifiers are numbered and can be freely selected or entered;
进一步的,输出基于母乳分析计算的母乳强化剂袋数D1包括:Further, outputting the number of bags of human milk fortifier D1 calculated based on human milk analysis includes:
Dmin= (Pmin* b * 0.01 * M + Pmin* h - a * 0.01 * M - g) / (d - Pmin* e *0.2389)D min = (P min * b * 0.01 * M + P min * h - a * 0.01 * M - g) / (d - P min * e *0.2389)
Dmax= (Pmax* b * 0.01 * M + Pmax* h - a * 0.01 * M - g) / (d - Pmax* e *0.2389)D max = (P max * b * 0.01 * M + P max * h - a * 0.01 * M - g) / (d - P max * e *0.2389)
Dmin<D1<Dmax D min < D1 < D max
Dmax为母乳强化剂所需最大袋数,Dmin为母乳强化剂所需最小袋数,D1为基于母乳分析计算的母乳强化剂袋数,M为母乳量(mL),W为所诉早产儿体重(kg),a为母乳蛋白质(g/dL),b为母乳能量(kcal/dL),d为不同品牌母乳强化剂蛋白质(g/袋),e为不同品牌母乳强化剂能量(kj/袋),g为早产儿摄入的其他蛋白质(g),h为早产儿摄入的其他能量(kcal),一般默认g和h值为0。其中,d、e、f的取值根据母乳强化剂的品牌不同而变化,具体见表1:D max is the maximum number of bags of breast milk fortifier required, D min is the minimum number of bags of breast milk fortifier required, D1 is the number of bags of breast milk fortifier calculated based on breast milk analysis, M is the amount of breast milk (mL), W is the weight of the premature infant in question (kg), a is breast milk protein (g/dL), b is breast milk energy (kcal/dL), d is the protein of different brands of breast milk fortifiers (g/bag), e is the energy of different brands of breast milk fortifiers (kj/bag), g is other proteins ingested by premature infants (g), h is other energy ingested by premature infants (kcal), and the default values of g and h are generally 0. Among them, the values of d, e, and f vary according to the brand of breast milk fortifier, as shown in Table 1:
表1:不同母乳强化剂品牌的参数输入Table 1: Parameter input for different brands of human milk fortifiers
优选的实施例中,母乳强化剂品牌由目标早产儿家庭自行选择。In a preferred embodiment, the brand of human milk fortifier is selected by the family of the target premature infant.
进一步的,所述获取目标早产儿的母乳强化剂使用天数和血尿素氮水平,包括:母乳强化剂使用天数和每周至少两次血尿素氮水平的检测情况。Furthermore, the obtaining of the number of days of use of human milk fortifier and the blood urea nitrogen level of the target premature infant includes: the number of days of use of human milk fortifier and the detection of the blood urea nitrogen level at least twice a week.
进一步的,所述基于母乳强化剂使用天数和血尿素氮水平生成调整母乳强化剂的策略,包括:基于每袋母乳强化剂克数、母乳强化剂使用天数和每周两次血尿素氮水平的检测情况调整母乳强化剂的添加量,并决定是否需要在早产儿母乳中添加额外的蛋白质。Furthermore, the strategy for adjusting the human milk fortifier based on the number of days the human milk fortifier is used and the blood urea nitrogen level includes: adjusting the amount of human milk fortifier added based on the grams of human milk fortifier per bag, the number of days the human milk fortifier is used and the detection of blood urea nitrogen levels twice a week, and determining whether additional protein needs to be added to the breast milk of premature infants.
进一步的,输出母乳强化剂调整策略包括:Further strategies for adjusting the output of human milk fortifiers include:
当BUN在10mg/dL~16mg/dL时,继续标准强化(0级);When BUN is between 10 mg/dL and 16 mg/dL, continue standard fortification (level 0);
当BUN<10mg/dL时,强化程度提高1级,即1级为100mL母乳中添加5g母乳强化剂及0.4g额外的蛋白质;When BUN is less than 10 mg/dL, the fortification level is increased by 1 level, that is, level 1 is the addition of 5 g of breast milk fortifier and 0.4 g of additional protein to 100 mL of breast milk;
若BUN仍<10mg/dL,再提高1级,2级为100mL母乳中添加5g母乳强化剂及0.8g额外的蛋白质,3级为100mL母乳中添加5g母乳强化剂及1.2g额外的蛋白质;If BUN is still <10 mg/dL, increase by one level, level 2 is to add 5 g of breast milk fortifier and 0.8 g of additional protein to 100 mL of breast milk, and level 3 is to add 5 g of breast milk fortifier and 1.2 g of additional protein to 100 mL of breast milk;
如果BUN>16mg/dL,强化程度降低1级,即-1级为100mL母乳中添加3.75g母乳强化剂,若BUN仍>16mg/dL,再降低1级,-2级为100mL母乳中添加2.5g母乳强化剂。If BUN is >16 mg/dL, the fortification level is reduced by 1 level, that is, level -1 means adding 3.75 g of breast milk fortifier to 100 mL of breast milk. If BUN is still >16 mg/dL, it is reduced by another level, that is, level -2 means adding 2.5 g of breast milk fortifier to 100 mL of breast milk.
本发明的有益效果Beneficial effects of the present invention
本发明给出了一种早产儿母乳强化剂个体化管理系统,使用电子健康记录和其他信息技术工具可以帮助护理团队记录和跟踪早产儿的营养摄入、生长数据和健康结果,从而更有效地管理母乳强化剂的使用。早产儿母乳强化剂的个体化管理系统不仅能够提高营养支持的针对性和有效性,也体现了营养支持的精细化和人性化趋势。本发明操作简易,耗费时间短,可用于在一般社区和基层卫生机构应用推广。The present invention provides an individualized management system for breast milk fortifiers for premature infants. The use of electronic health records and other information technology tools can help the nursing team record and track the nutritional intake, growth data and health outcomes of premature infants, thereby more effectively managing the use of breast milk fortifiers. The individualized management system for breast milk fortifiers for premature infants can not only improve the pertinence and effectiveness of nutritional support, but also reflect the trend of refined and humanized nutritional support. The present invention is easy to operate, takes a short time, and can be used for application and promotion in general communities and primary health institutions.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为本发明一种早产儿母乳强化剂个体化管理系统的结构框图。FIG1 is a structural block diagram of an individualized management system for premature infant breast milk fortifiers according to the present invention.
图2为本发明一种早产儿母乳强化剂个体化管理系统的流程框图。FIG2 is a flowchart of an individualized management system for breast milk fortifier for premature infants according to the present invention.
图3为本发明一种早产儿母乳强化剂个体化管理系统的详细流程示意图。FIG3 is a detailed schematic diagram of a system for managing an individualized management system for breast milk fortifiers for premature infants according to the present invention.
具体实施方式DETAILED DESCRIPTION
本申请实施例提供一种早产儿母乳强化剂个体化管理系统,该早产儿母乳强化剂个体化管理系统可为电子设备,该电子设备可以为服务器也可以为终端设备,其中该服务器可以是独立的物理服务器,也可以是多个物理服务器构成的服务器集群或者分布式系统,还可以是提供云计算服务的云服务器。终端设备可以是智能手机、平板电脑、台式计算机等,但并不局限于此。The embodiment of the present application provides an individualized management system for breast milk fortifier for premature infants, which can be an electronic device, which can be a server or a terminal device, wherein the server can be an independent physical server, or a server cluster or distributed system composed of multiple physical servers, or a cloud server providing cloud computing services. The terminal device can be a smart phone, a tablet computer, a desktop computer, etc., but is not limited thereto.
结合图1一种早产儿母乳强化剂个体化管理系统,它包括信息获取模块、母乳含量分析模块、血尿素氮测量模块、策略生成模块;其中:In conjunction with FIG1 , a premature infant breast milk fortifier individualized management system includes an information acquisition module, a breast milk content analysis module, a blood urea nitrogen measurement module, and a strategy generation module; wherein:
信息获取模块:获得所述目标早产儿的出生天数、体重和当天母乳喂养量;获取不同母乳强化剂品牌蛋白质和能量;Information acquisition module: obtaining the birth day, weight and breast milk feeding amount of the target premature infant on the same day; obtaining the protein and energy of different brands of breast milk fortifiers;
母乳含量分析模块:测量目标产妇母乳中的蛋白质和母乳能量;Breast milk content analysis module: measures the protein and breast milk energy in the target mother’s breast milk;
血尿素氮测量模块:所述目标早产儿使用母乳强化剂后,血尿素氮测量模块监测目标早产儿的血尿素氮水平;Blood urea nitrogen measurement module: after the target premature infant uses the breast milk fortifier, the blood urea nitrogen measurement module monitors the blood urea nitrogen level of the target premature infant;
策略生成模块:基于目标早产儿的出生天数和体重、母乳量、母乳蛋白质、母乳能量、不同母乳强化剂品牌蛋白质和能量、早产儿摄入的蛋白/能量比,生成母乳强化剂的添加袋数;基于每袋母乳强化剂克数、母乳强化剂使用天数和血尿素氮水平,生成调整母乳强化剂的策略。Strategy generation module: Generates the number of bags of human milk fortifier to be added based on the birth days and weight of the target premature infants, the amount of breast milk, breast milk protein, breast milk energy, protein and energy of different brands of breast milk fortifiers, and the protein/energy ratio consumed by premature infants; generates a strategy for adjusting human milk fortifiers based on the grams of breast milk fortifier per bag, the number of days the breast milk fortifier is used, and the blood urea nitrogen level.
本发明提供了如图2-3的一种早产儿母乳强化剂个体化管理系统。The present invention provides an individualized management system for premature infant breast milk fortifiers as shown in Figures 2-3.
如图2所示,一种早产儿母乳强化剂个体化管理系统,获取目标早产儿的出生信息和当前信息;基于所述出生信息和所述当前信息确定所述目标早产儿的出生天数和体重;获取目标产妇的母乳信息;基于仪器测量确定目标产妇母乳中的蛋白质和母乳能量;获取不同母乳强化剂品牌蛋白质和能量;基于目标早产儿的出生天数和体重、母乳量、母乳蛋白质、母乳能量、不同母乳强化剂品牌蛋白质和能量、早产儿摄入的蛋白/能量比生成母乳强化剂的添加袋数;获取所述目标早产儿的母乳强化剂使用天数和血尿素氮水平;基于每袋母乳强化剂克数、母乳强化剂使用天数和血尿素氮水平生成调整母乳强化剂的策略。As shown in FIG2 , a personalized management system for breast milk fortifiers for premature infants is provided, which obtains birth information and current information of a target premature infant; determines the birth days and weight of the target premature infant based on the birth information and the current information; obtains breast milk information of a target pregnant woman; determines the protein and breast milk energy in the breast milk of the target pregnant woman based on instrument measurement; obtains the protein and energy of different brands of breast milk fortifiers; generates the number of bags of breast milk fortifier to be added based on the birth days and weight of the target premature infant, the amount of breast milk, breast milk protein, breast milk energy, the protein and energy of different brands of breast milk fortifiers, and the protein/energy ratio ingested by the premature infant; obtains the number of days of use of the breast milk fortifier and the blood urea nitrogen level of the target premature infant; and generates a strategy for adjusting the breast milk fortifier based on the grams of each bag of breast milk fortifier, the number of days of use of the breast milk fortifier, and the blood urea nitrogen level.
所述获取目标早产儿的出生信息和当前信息,包括:早产儿的出生天数、体重和当天喂养量。The acquisition of the birth information and current information of the target premature infant includes: the premature infant's birth day, weight, and daily feeding amount.
所述基于出生信息和所述当前信息确定所述目标早产儿的出生天数、体重和当天喂养量包括:根据出生信息和所述当前信息确定目标早产儿当天的喂养量和体重,用于后续判断是否需要使用母乳强化剂。Determining the birth day, weight and daily feeding amount of the target premature infant based on the birth information and the current information includes: determining the daily feeding amount and weight of the target premature infant based on the birth information and the current information, for subsequent determination of whether a breast milk fortifier is needed.
所述基于仪器测量确定母乳中的蛋白质和母乳能量:获取所述母乳中的蛋白质和能量。The method of determining the protein and energy in breast milk based on instrumental measurement includes obtaining the protein and energy in the breast milk.
将目标早产儿的体重和当天喂养量输入到系统中,The target premature infant's weight and daily feeding amount are input into the system.
N=(W,M)N=(W,M)
若W<1.8kg,且M>W × 50 则需要使用母乳强化剂;If W < 1.8 kg and M > W × 50, a human milk fortifier is required;
其中,N为需要添加母乳强化剂的早产儿,M为母乳量(mL),W为所诉早产儿体重(kg)。Wherein, N is the premature infant who needs to add breast milk fortifier, M is the amount of breast milk (mL), and W is the weight of the premature infant (kg).
所述基于目标早产儿的出生天数、体重、当天喂养量、母乳蛋白质、母乳能量、不同母乳强化剂品牌蛋白质和能量、早产儿摄入的蛋白/能量比。The method is based on the target premature infant's days of birth, weight, daily feeding amount, breast milk protein, breast milk energy, protein and energy of different brands of breast milk fortifiers, and the protein/energy ratio consumed by the premature infant.
将不同母乳强化剂品牌所含的蛋白质、当天喂养量、目标产妇的母乳蛋白质、目标产妇的母乳能量、输入到系统中,输出基于母乳分析计算的母乳强化剂袋数D1的添加范围包括:The protein content of different brands of breast milk fortifiers, the daily feeding amount, the target mother's breast milk protein, and the target mother's breast milk energy are input into the system, and the output is the number of breast milk fortifier bags D1 calculated based on breast milk analysis. The addition range includes:
蛋白/能量的范围为0.032-0.041;The protein/energy range was 0.032-0.041;
Dmin= (Pmin* b * 0.01 * M + Pmin* h - a * 0.01 * M - g) / (d - Pmin* e *0.2389)D min = (P min * b * 0.01 * M + P min * h - a * 0.01 * M - g) / (d - P min * e *0.2389)
Dmax= (Pmax* b * 0.01 * M + Pmax* h - a * 0.01 * M - g) / (d - Pmax* e *0.2389)D max = (P max * b * 0.01 * M + P max * h - a * 0.01 * M - g) / (d - P max * e *0.2389)
其中,d、e、f的取值根据母乳强化剂的品牌不同而变化,具体见表1。Among them, the values of d, e, and f vary according to the brand of human milk fortifier, as shown in Table 1.
Emin= (b * M * 0.01) + (e * 0.2389 * Dmin) + hE min = (b * M * 0.01) + (e * 0.2389 * D min ) + h
若Emin >W * 100,输出基于母乳分析计算的母乳强化剂袋数D1的取值范围:If E min >W * 100, output the value range of the number of breast milk fortifier bags D1 calculated based on breast milk analysis:
Dmin<D1<=Dmax D min <D1<=D max
其中,Dmax为母乳强化剂所需最大袋数,Dmin为母乳强化剂所需最小袋数,D1为基于母乳分析计算的母乳强化剂袋数,a为母乳蛋白质(g/dL),b为母乳能量(kcal/dL),d为不同品牌母乳强化剂蛋白质(g/袋),e为不同品牌母乳强化剂能量(kj/袋),g为早产儿摄入的其他蛋白质(g),h为早产儿摄入的其他能量(kcal),一般默认g和h值为0。Wherein, D max is the maximum number of bags of human milk fortifier required, D min is the minimum number of bags of human milk fortifier required, D1 is the number of bags of human milk fortifier calculated based on human milk analysis, a is human milk protein (g/dL), b is human milk energy (kcal/dL), d is the protein of different brands of human milk fortifier (g/bag), e is the energy of different brands of human milk fortifier (kj/bag), g is other protein ingested by premature infants (g), and h is other energy ingested by premature infants (kcal). Generally, the default values of g and h are 0.
进一步的,所述获取目标早产儿的每袋母乳强化剂克数、母乳强化剂使用天数和血尿素氮水平,包括:每袋母乳强化剂克数、母乳强化剂的使用天数和每周两次血尿素氮水平的检测情况;Furthermore, the obtaining of the grams of each bag of breast milk fortifier, the number of days the breast milk fortifier is used, and the blood urea nitrogen level of the target premature infant includes: the grams of each bag of breast milk fortifier, the number of days the breast milk fortifier is used, and the detection of the blood urea nitrogen level twice a week;
进一步的,所述基于母乳强化剂使用天数判断早产儿是否需要进入全量强化阶段,并生成调整母乳强化剂的策略,包括:基于每袋母乳强化剂克数、每周两次血尿素氮水平的检测情况调整母乳强化剂的添加量,并决定是否需要在早产儿母乳中添加额外的蛋白质:Furthermore, judging whether premature infants need to enter the full fortification stage based on the number of days of use of the breast milk fortifier and generating a strategy for adjusting the breast milk fortifier include: adjusting the amount of breast milk fortifier added based on the grams of each bag of breast milk fortifier and the detection of blood urea nitrogen levels twice a week, and determining whether additional protein needs to be added to premature infant breast milk:
若T1>3,则进入全量强化阶段;If T1>3, it will enter the full-strengthening stage;
T1为母乳强化剂的使用天数;T1 is the number of days the human milk fortifier was used;
输入早产儿血尿素氮、全量强化天数、不同母乳强化剂品牌的每袋克数到系统中:Enter the blood urea nitrogen of premature infants, the number of days of full fortification, and the grams per bag of different brands of human milk fortifiers into the system:
T2=T1-3T2=T1-3
T2为全量强化天数,BUN为早产儿血尿素氮,i, j, k 分别为 3.5、7、10.5天,f为每袋母乳强化剂克数,D2为基于早产儿代谢反应计算的母乳强化剂袋数。T2 is the number of days of full fortification, BUN is the blood urea nitrogen of premature infants, i, j, k are 3.5, 7, and 10.5 days, respectively, f is the grams of each bag of human milk fortifier, and D2 is the number of bags of human milk fortifier calculated based on the metabolic response of premature infants.
输出母乳强化剂调整策略见表2:The strategy for adjusting the output human milk fortifier is shown in Table 2:
表2:母乳强化剂调整策略Table 2: Strategies for adjusting human milk fortifiers
本系统算法设计依据为:当P/E(protein/energy,蛋白/能量比)为3.2~4.1 g/100kcal且摄入能量>100 kcal/(kg•d)时,接近正常胎儿宫内参照值。则:The algorithm design of this system is based on the following: When P/E (protein/energy ratio) is 3.2~4.1 g/100kcal and energy intake is >100 kcal/(kg•d), it is close to the normal fetal intrauterine reference value. Then:
P=母乳蛋白质(g/dL)×0.01×母乳量(mL) + 每袋母乳强化剂蛋白质(g/袋)×袋数 +其他蛋白质(g)P = breast milk protein (g/dL) × 0.01 × breast milk volume (mL) + breast milk fortifier protein per bag (g/bag) × number of bags + other proteins (g)
E=母乳能量(kcal/dL)×0.01×母乳量(mL) +每袋母乳强化剂能量(kj/袋)×0.2389×袋数 +其他能量(kcal)E = breast milk energy (kcal/dL) × 0.01 × breast milk volume (mL) + energy per bag of breast milk fortifier (kj/bag) × 0.2389 × number of bags + other energy (kcal)
结合以下算式:Combined with the following formula:
母乳量(mL)=MBreast milk volume (mL) = M
母乳蛋白质(g/dL)=aBreast milk protein (g/dL) = a
每袋母乳强化剂蛋白质(g/袋)=dProtein per bag of human milk fortifier (g/bag) = d
其他蛋白质(g)=gOther protein (g) = g
母乳能量(kcal/dL)=bBreast milk energy (kcal/dL) = b
每袋母乳强化剂能量(kcal/袋)=eEnergy per bag of breast milk fortifier (kcal/bag) = e
其他能量(kcal)=hOther energy (kcal) = h
母乳强化剂袋数(袋)=D (D未知,其余字母均已知)Number of bags of human milk fortifier (bag) = D (D is unknown, the rest of the letters are known)
可以得到:You can get:
P=a×0.01×M + d×D + gP = a × 0.01 × M + d × D + g
E=b×0.01×M + e×0.2389×D + hE=b×0.01×M + e×0.2389×D + h
g为早产儿摄入的其他蛋白质(g),h为早产儿摄入的其他能量(kcal),对于早产儿默认g和h值为0。g is other protein intake by premature infants (g), and h is other energy intake by premature infants (kcal). For premature infants, the default values of g and h are 0.
根据(P/E)min = 0.032,(P/E)max = 0.041,得:According to (P/E) min = 0.032, (P/E) max = 0.041, we get:
Dmin= (Pmin* b * 0.01 * M + Pmin* h - a * 0.01 * M - g) / (d - Pmin* e *0.2389)D min = (P min * b * 0.01 * M + P min * h - a * 0.01 * M - g) / (d - P min * e *0.2389)
Dmax= (Pmax* b * 0.01 * M + Pmax* h - a * 0.01 * M - g) / (d - Pmax* e *0.2389)D max = (P max * b * 0.01 * M + P max * h - a * 0.01 * M - g) / (d - P max * e *0.2389)
本申请的创造性在于给定了一个早产儿母乳强化剂使用的个体化科学算法,并结合该算法设计了一套完整的管理系统,基于本系统,针对不同的早产儿给出相应具体的母乳强化剂使用量,不仅能够提高营养支持的针对性和有效性,也体现了营养支持的精细化和人性化趋势。本系统使用操作简易,耗费时间短。The creativity of this application lies in providing an individualized scientific algorithm for the use of breast milk fortifiers for premature infants, and designing a complete management system based on the algorithm. Based on this system, specific breast milk fortifier usage is given for different premature infants, which can not only improve the pertinence and effectiveness of nutritional support, but also reflect the trend of refined and humanized nutritional support. This system is easy to use and takes little time.
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对本发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属手本发明的保护范国。因此,本发明专利的保护范围应以所附权利要求为准。The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the patent of the present invention. It should be pointed out that, for ordinary technicians in this field, several modifications and improvements can be made without departing from the concept of the present invention, which are all within the scope of protection of the present invention. Therefore, the scope of protection of the patent of the present invention shall be based on the attached claims.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410955240.0A CN118506984B (en) | 2024-07-17 | 2024-07-17 | Personalized management system for breast milk fortifier of premature infant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410955240.0A CN118506984B (en) | 2024-07-17 | 2024-07-17 | Personalized management system for breast milk fortifier of premature infant |
Publications (2)
Publication Number | Publication Date |
---|---|
CN118506984A CN118506984A (en) | 2024-08-16 |
CN118506984B true CN118506984B (en) | 2024-10-29 |
Family
ID=92233090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410955240.0A Active CN118506984B (en) | 2024-07-17 | 2024-07-17 | Personalized management system for breast milk fortifier of premature infant |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118506984B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104080457A (en) * | 2011-12-01 | 2014-10-01 | 婴儿护理药品公司 | Methods for treating hyperbilirubinemia with stannsoporfin |
CN107358033A (en) * | 2017-06-26 | 2017-11-17 | 广东省人民医院(广东省医学科学院) | Appraisal procedure for the intake of Patients with Chronic Kidney Disease dietary protein |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294206B1 (en) * | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
SE536599C3 (en) * | 2012-04-10 | 2017-01-10 | Hero Ag | Nutritional composition with low calorie and low protein content |
CN114469605A (en) * | 2022-03-08 | 2022-05-13 | 安徽医科大学第一附属医院 | A family support and nursing platform for premature infants |
CN116092637B (en) * | 2023-03-06 | 2023-06-27 | 深圳市奥极医疗科技有限公司 | Method, device, equipment and storage medium for managing lactation of infants during lactation period |
-
2024
- 2024-07-17 CN CN202410955240.0A patent/CN118506984B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104080457A (en) * | 2011-12-01 | 2014-10-01 | 婴儿护理药品公司 | Methods for treating hyperbilirubinemia with stannsoporfin |
CN107358033A (en) * | 2017-06-26 | 2017-11-17 | 广东省人民医院(广东省医学科学院) | Appraisal procedure for the intake of Patients with Chronic Kidney Disease dietary protein |
Also Published As
Publication number | Publication date |
---|---|
CN118506984A (en) | 2024-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Colaizy et al. | Growth in VLBW infants fed predominantly fortified maternal and donor human milk diets: a retrospective cohort study | |
Neifert et al. | Overcoming clinical barriers to exclusive breastfeeding | |
Hallowell et al. | The relationship of brain development and breastfeeding in the late-preterm infant | |
Kültürsay et al. | Turkish Neonatal Society guideline on enteral feeding of the preterm infant | |
Travers et al. | Higher-or usual-volume feedings in infants born very preterm: a randomized clinical trial | |
Naaz et al. | How maternal nutritional and mental health affects child health during pregnancy: a narrative review | |
Lovelady | Is maternal obesity a cause of poor lactation performance? | |
Atkinson | Human milk feeding of the micropremie | |
Henderson et al. | Calorie and protein‐enriched formula versus standard term formula for improving growth and development in preterm or low birth weight infants following hospital discharge | |
Mulder et al. | Excessive weight loss in breastfed infants during the postpartum hospitalization | |
Gardner et al. | Comparison of maternal milk ejection characteristics during pumping using infant-derived and 2-phase vacuum patterns | |
Matheny et al. | Control of intake by human‐milk‐fed infants: Relationships between feeding size and interval | |
CN118506984B (en) | Personalized management system for breast milk fortifier of premature infant | |
Riley | Weight management before, during and after pregnancy-what are the'rules'? | |
Alur et al. | Calorie intake is associated with weight gain during transition phase of nutrition in female extremely low birth weight infants | |
CN203965002U (en) | A kind of food-intake and interval time automatic monitoring record system | |
Warner et al. | Growth and metabolic responses in preterm infants fed fortified human milk or a preterm formula | |
Tewari et al. | Proportionate postnatal growth in preterm neonates on expressed breast milk feeding with selected fortification | |
Arnold | Trends in donor milk banking in the United States | |
Roschnik et al. | Malawi stories of change in nutrition: Evidence review | |
Gupta et al. | Nutrition Management of High-Risk Neonates After Discharge | |
Rutherford et al. | Dietary calcium in galactosaemia | |
Aiken et al. | Calcium and phosphate content of intravenous feeding regimens for very low birthweight infants. | |
Sanderson et al. | Supratherapeutic maternal iodine supplementation during pregnancy as a cause for congenital hypothyroidism | |
Paramasivam et al. | Life threatening severe hypernatraemic dehydration in neonates: A report of two cases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |